Race Oncology Ltd (FRA:FN3)
€ 0.785 -0.04 (-4.85%) Market Cap: 142.35 Mil Enterprise Value: 131.76 Mil PE Ratio: 0 PB Ratio: 12.31 GF Score: 42/100

Race Oncology Ltd to Discuss its Board Renewal Transcript

Sep 02, 2024 / NTS GMT
Release Date Price: €1.01 (+1.00%)
Jane Lowe
Race Oncology Ltd - MD, IR

Hello, everyone. My name is Jane Lowe. I'm the Managing Director of IR Department, and it's my great pleasure to support Race Oncology with Investor Relations. I'm here today with the Race Board, and we plan to discuss the announcement that was released this morning regarding Board renewal, so Pete we might start with you. Could you walk us through the key components of today's announcement.

Peter Smith
Race Oncology Ltd - Executive Chair

Thanks, Jane. Before we get into all of that, the first thing I want to do is really thank Phil and Mary for the service they've given to Race. I have thoroughly enjoyed working with them at a personal level and also professional level over the past 12 months. I know that contributed a great deal to the company. Certainly stepping into the chair. I feel like those are big shoes to Phil, Mary's has been an excellent chair, very rigorous, very, very professional.

And again, I've really enjoyed working with her. The very honored to step up to the chair role at Race. I've been extremely

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot